Watchlists Portfolios Alerts Sign in Get started

Menu

SBIO

ALPS Medical Breakthroughs ETF

USD

Set alert

54.87 USD -1.16 -2.07%

As of Oct 30, 2026 Extended hours 54.87 0.00%

Bid: 54.84 × 200
Ask: 54.98 × 2,900

54.19 Day range 56.27

43.65 52-week range 70.79

YTD: +7.13%
1 year: +22.75%

Open: 55.49
Prev close: 56.03
Mkt cap: 189.16M
Vol: 16.60K
Avg vol: 39.56K
EPS: 0.00
P/E: 0.00
Div yield: 0.00%

More statistics

Low: 54.19
High: 56.27
Forward P/E: 0.00
Beta: 0.00
Short ratio: 0.00
Dividend: 0.00
Ex-div date
50-d avg: 38.30
200-d avg: 35.94

Chart tools

Interval

Chart is warming up

The five-day price history for SBIO has not been loaded yet. Try again in a moment.

Issuer: ALPS Funds
Asset class: Equity
Expense ratio: 0.50%
Assets under management: $183.93M
NAV: 54.91
Holdings: 103
Inception: 2014-12-30
Top 10 weight: 31.76%

ORKA Oruka Therapeutics Inc. 4.27%
MANE VeraDermics Inc. 3.88%
CGON CG oncology Inc. 3.82%
DFTX Definium Therapeutics Inc. 3.25%
TVTX Travere Therapeutics Inc. 3.16%
DNTH Dianthus Therapeutics Inc. 3.07%
EWTX Edgewise Therapeutics Inc. 2.81%
RLAY Relay Therapeutics Inc. 2.68%
AMLX Amylyx Pharmaceuticals Inc. 2.41%
XENE Xenon Pharmaceuticals Inc. 2.41%
ACAD ACADIA Pharmaceuticals Inc. 2.36%
TARS Tarsus Pharmaceuticals Inc. 2.19%
DYN Dyne Therapeutics Inc. 2.07%
IRON Disc Medicine Inc. 2.07%
IDYA Ideaya Biosciences Inc. 2.05%
DNLI Denali Therapeutics Inc. 2.02%
VRDN Viridian Therapeutics Inc. 1.86%
MBX MBX Biosciences Inc. 1.79%
ZLAB Zai Lab Ltd. 1.65%
NAMS Newamsterdam Pharma Co. NV 1.60%
CLDX Celldex Therapeutics Inc. 1.57%
VERA Vera Therapeutics Inc. 1.49%
XNCR Xencor Inc. 1.48%
BCRX BioCryst Pharmaceuticals Inc. 1.44%
LKFT Lakefront Biotherapeutics NV 1.43%

Healthcare 100.00%

United States 91.87%
Canada 2.37%
United Kingdom 1.83%
China 1.73%
Netherlands 1.62%
Switzerland 0.33%
Belgium 0.25%

Updated 2026-10-31

No holders on record

No holders on record

No insider holdings on record